DocMorris H1 FY26 adjusted EBITDA loss narrows 62.15% to CHF 10.9 million; revenue rises 13.4% to CHF 599.2 million

(AWP Alliance News) - DocMorris reported H1 2026 revenue rose 13.4% to CHF 599.2 million, while net loss narrowed to CHF 53.1 million. Adjusted EBITDA improved to a loss of CHF 10.9 million from a deeper loss a year earlier, supported by improved marketing efficiency in Rx and higher profit contributions from Digital Services.

Germany Rx external revenue climbed 38.3% to CHF 147.9 million, while Digital Services revenue jumped 71.4% and EBITDA doubled. The group raised its 2026 outlook, forecasting external revenue growth of 9% to 13% and adjusted EBITDA of minus CHF 10 million to minus CHF 17.5 million, and reiterated its target to reach EBITDA breakeven in H2 2026.

https://www.publicnow.com/view/6BB0DFA50595C41BCB95C944C37B7BAB2422798C…

Disclaimer: This news brief was created using generative artificial intelligence. DocMorris AG published the original content used to generate this news brief via EQS News on August 19, 2026, and is solely responsible for the information contained therein.